Internal Medicine, Pulmonary Disease · Gainesville, FL
NPI
1255524518
Since 2007
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
1600 SW Archer Rd
Gainesville, FL, 32610
Phone (352) 273-8737
Groups this clinician bills Medicare through
Medicare paid, 2024
$27K
236 services
Medicare patients, 2024
96
Average age 70
Drug cost, 2024
$882K
229 prescriptions
Company payments, 2025
$1,188
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Karina A Serban was code 99291 (critical care e&m), 87 times for 44 patients. In total Karina A Serban billed 236 services in 26 codes, and Medicare paid $27K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-10-03.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99291 Critical Care E&M | Facility | 87 | 44 | $175.51 | $15K |
| 99233 Hospital E&M - Subsequent | Facility | 28 | 20 | $88.56 | $2,480 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 19 | 17 | $13.53 | $257 |
| 99214 Office E&M - Established | Office | 17 | 14 | $104.70 | $1,780 |
| 99204 Office E&M - New | Office | 12 | 12 | $126.02 | $1,512 |
By year: 2022 $12K for 114 services; 2023 $17K for 151 services; 2024 $27K for 236 services.
Medicare prescription drug claims, 2024
In 2024, the drug Karina A Serban prescribed most often to Medicare patients was Prolastin C (Alpha-1-Proteinase Inhibitor), with 40 prescriptions and refills. In total Karina A Serban wrote 229 Medicare prescriptions that cost $882K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Prolastin C Alpha-1-Proteinase Inhibitor | 40 | 40 | Under 11 | $530K |
| Zemaira Alpha-1-Proteinase Inhibitor | 22 | 22 | Under 11 | $260K |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 20 | 28 | Under 11 | $18K |
| Albuterol Sulfate Hfa Albuterol Sulfate | 17 | 18 | Under 11 | $366 |
| Prednisone Generic | 15 | 15 | Under 11 | $46.03 |
| Roflumilast Generic | 14 | 16 | Under 11 | $1,606 |
| Azithromycin Generic | 11 | 22 | Under 11 | $208 |
Brand drugs: 140 claims; generic drugs: 89 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Karina A Serban $1,188 ($1,188 in general payments such as food, travel and fees) from 2 companies. The largest payer was Takeda Pharmaceuticals U.S.A., Inc. with $1,188.
| Company | Payments | Amount |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 1 | $1,188 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.